Abdi Ibrahim Holding

Abdi İbrahim is the leading pharmaceutical company in Turkey, maintaining a dominant market position since 2002 with a history dating back to 1912. The company operates a vast portfolio that includes branded generics, licensed innovative products, and a growing pipeline of biosimilars developed through its dedicated biotechnology division, AbdiBio. With one of the most advanced pharmaceutical manufacturing complexes in Europe and the Middle East, Abdi İbrahim provides extensive contract development and manufacturing (CDMO) services to global pharmaceutical partners. The company has a significant international presence, exporting to over 60 countries and operating production facilities in Kazakhstan and Algeria. Its business model focuses on high-tech production, international expansion, and strategic partnerships with global leaders like Otsuka and GSK.